Company Filing History:
Years Active: 2002
Title: The Innovative Contributions of Marco Zlicar
Introduction
Marco Zlicar is a notable inventor based in Celje, Slovenia. He has made significant contributions to the field of pharmaceuticals, particularly in the development of processes for the preparation of important cholesterol-lowering agents.
Latest Patents
Marco Zlicar holds a patent for a novel method related to the preparation of simvastatin and its analogs. His patent, titled "Process for the preparation of simvastatin and analogs thereof," focuses on the acylation of sterically hindered alcohols. This method is crucial in the production of simvastatin, lovastatin, pravastatin, and other derivatives, which are known as HMG-CoA reductase inhibitors. These compounds are widely used as antihypercholesterolemic agents and are primarily produced through fermentation using various microorganisms.
Career Highlights
Marco Zlicar is associated with Lek Pharmaceutical and Chemical Company D.d., where he applies his expertise in pharmaceutical innovation. His work has contributed to advancements in the production of essential medications that help manage cholesterol levels in patients.
Collaborations
(Section skipped due to space constraints.)
Conclusion
Marco Zlicar's innovative work in the pharmaceutical industry, particularly in the development of processes for simvastatin and its analogs, showcases his valuable contributions to healthcare. His patent reflects a significant advancement in the production of vital medications.